









Markets
/
Stocks
/
nasdaq-veev
/

Veeva Systems Inc

VEEV



View Detailed Chart

242.000USD

-0.320-0.13%

Close 12/05, 16:00（ET）Quotes delayed by 15 min

39.77BMarket Cap

46.23P/E TTM



Veeva Systems Inc

242.000

-0.320-0.13%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

-0.13%

5 Days

+0.71%

1 Month

-17.93%

6 Months

-15.19%

Year to Date

+15.10%

1 Year

-3.37%

View Detailed Chart

TradingKey Stock Score of Veeva Systems Inc

Currency: USD Updated: 2025-12-05

Key Insights

Veeva Systems Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 312.78.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Veeva Systems Inc's Score

Industry at a Glance

Industry Ranking

73 / 207

Overall Ranking

157 / 4582

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 34 analysts

Buy

Current Rating

312.781

Target Price

+29.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Veeva Systems Inc Highlights

StrengthsRisks

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.45% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.75B.

Undervalued

The company’s latest PE is 45.95, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 145.54M shares, decreasing 1.03% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 1.57K shares of this stock.